Posts filtered by tags: Vaccines[x]


 

Want to Know What the Covid-19 Vaccine Trials Are Like? There's a TikTok for That

The viral short-form video app TikTok (which still isn’t banned, by the way) is becoming the unlikely new home for creators claiming to have first-hand experience with the covid-19 vaccine and giving expert testimonials about ongoing vaccine trials.Read more...
Tags: Science, Vaccines, Tiktok, Covid 19, Sars Cov 2, Of Course There Is


UK adds 2 million doses of Moderna's COVID-19 vaccine, upping stockpile to 357 million doses

In the UK frontline workers are expected to be first in line to receive the Moderna vaccine. Moderna; Samantha Lee/Business Insider The UK government said on Sunday it added 2 million Moderna COVID-19 vaccine doses to its stockpile, bringing the total to 357 million, according to a press release.   The prime minister, Boris Johnson, appointed Nadhim Zahawi, minister for business and industry, to oversee the vaccine rollout. Johnson is also urging ministers to approve a new lockdown system,...
Tags: Health, Politics, UK, Trends, Healthcare, Astrazeneca, Boris Johnson, Pfizer, University of Oxford, Johnson, Vaccines, Reuters, Sanofi, GSK, Novavax, Matt Hancock


Vaccine experts report that the rapid progress on COVID-19 trials is a result of unprecedented global cooperation and focus

John Cairns On November 19 Oxford University announced that its own COVID-19 vaccine, developed in collaboration with AstraZeneca, produced a safe immune response in older adults. Sarah Gilbert, vaccine knowledge project manager at Oxford University, said that the removal of traditional barriers in vaccine development have facilitated the rapid progress. Because of her work, Business Insider named Gilbert to our annual list of the 10 leaders transforming healthcare in Europe...
Tags: Europe, UK, England, US, Trends, United States, Healthcare, United Arab Emirates, Astrazeneca, Fda, Pfizer, Oxford University, Vaccines, Bahrain, Sarah Gilbert, Gilbert


Dosing Mix-up Raises Questions About Promising Covid-19 Vaccine

A manufacturing error is raising concerns about a promising covid-19 vaccine being developed by pharmaceutical company AstraZeneca and the University of Oxford.Read more...
Tags: Science, Astrazeneca, University of Oxford, Vaccines, Pandemic, Coronavirus, Covid 19


AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford reported interim results that showed 62% efficacy for a full two-dose regimen, and a 90% efficacy rate for a half-dose followed by a full dose – which t...
Tags: Health, TC, Tech, Bloomberg, Ceo, Medical Research, United States, Oxford, Astrazeneca, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Biotech, Vaccines


How to Talk to Someone Who Doesn't Want the COVID-19 Vaccine

As COVID-19 vaccines transition from the hypothetical to the actual, with Pfizer seeking an emergency use authorization from the Food & Drug Administration that could see the first Americans being inoculated against the disease as early as December, the discussion around actually taking a vaccine grows more personal. …Read more...
Tags: Pfizer, Lifehacks, Vaccines, Food Drug Administration


We now have the best evidence yet that coronavirus immunity lasts 6 to 8 months after infection, and perhaps even years

A medical staff member grabs the hand of a patient to reposition their bed in the COVID-19 intensive care unit at the United Memorial Medical Center, October 31, 2020 in Houston, Texas. Go Nakamura/Getty Images Immunity to the coronavirus involves more than just antibodies. T cells and B cells protect us long-term, too.  A new study found that these other elements of immunity persist at least eight months in a majority of COVID-19 patients and could protect most people against coronavirus ...
Tags: Health, Science, London, News, California, Trends, Healthcare, Vaccines, Antibodies, La Jolla, Houston Texas, NIAID, Immunity, United Memorial Medical Center, Crotty, Shane Crotty


Who Will Get the Vaccine First?

One COVID-19 vaccine is already under review for possible emergency authorization in December; its competitors are close behind. Once we have a vaccine—or maybe several—it will be a while until there are enough doses for everybody. The CDC is working on a plan to prioritize certain groups of people to get it first.Read more...
Tags: Cdc, Fda, Lifehacks, Vaccines, Coronavirus


How to interpret the 'efficacy' rates of coronavirus vaccines

A volunteer receives an injection for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa. The vaccine, developed by Oxford University's Jenner Institute, will inoculate 2,000 South Africans. Felix Dlangamandla/Beeld/Gallo Images via Getty Images Vaccine efficacy measures how well a vaccine works at preventing disease among vaccinated people, when compared to unvaccinated individuals. The vaccine efficacy numbers for coronavirus inj...
Tags: Science, News, US, Trends, Public Health, New York Times, Bill Gates, Astrazeneca, Pfizer, Oxford University, Vaccines, Times, Morgan Stanley, Anthony Fauci, Trevor Noah, Gates


Another Experimental Covid-19 Vaccine Seems Effective, Doesn't Need Extreme Cold Storage

On Monday, researchers in the UK became the latest to announce promising results from their experimental vaccine candidate against covid-19. In the data seen so far, the vaccine appeared to be at least 70% effective at preventing infection from the coronavirus, though it may be up to 90% effective with a certain…Read more...
Tags: UK, Science, Astrazeneca, Vaccines, Coronavirus, Covid 19


Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full strength dose to follow – that one was 90% effective. Oxford’s results may not ...
Tags: Health, TC, Messenger, Medicine, Tech, Medical Research, Oxford, Vaccination, Astrazeneca, Pfizer, Vaccine, Oxford University, Biotech, Vaccines, Moderna, COVID


Oxford University Covid vaccine, cheap and easy to store, is 70-90% effective

Oxford University and AstraZeneca today announced that their Covid vaccine is 70-90% effective depending on the dosing regimen. Though less effective than Pfizer and Moderna's vaccines, the Oxford vaccine is cheap, can be tranpsorted in a cooler, and a single dose can provide immunity. — Read the rest
Tags: Post, News, Oxford, Astrazeneca, Pfizer, Oxford University, Vaccines, Moderna, COVID


We're likely to need coronavirus booster shots after the initial vaccine

A volunteer receives an experimental coronavirus shot from a medical worker at Baragwanath Hospital in Soweto, South Africa, June 24, 2020. REUTERS/Siphiwe Sibeko People may need to get booster shots after the initial coronavirus vaccine doses in order to stay protected, experts say. Other vaccines, like the tetanus shot, also require periodic boosters.  That adds further complication to the impending challenge of distributing coronavirus vaccines, which are likely to require two doses. Vi...
Tags: Health, Science, News, New York City, Trends, Pfizer, University of Oxford, Vaccines, Mount Sinai, Chicago Illinois, Soweto South Africa, Icahn School of Medicine, ORENSTEIN, Moderna, Siphiwe Sibeko, Aylin Woodward


China's Xi Jinping pledged to work with other countries to accelerate COVID-19 vaccinations

Chinese President Xi Jinping. Noel Celis - Pool/Getty Images At the G20 Summit in Saudi Arabia, President Xi Jinping of China pledged to intensify cooperation on a global effort to develop vaccines for COVID-19, Reuters reported. Pfizer and BioNTech, as well as Moderna, have in the past two weeks announced vaccines that the companies maintain could be more than 90% effective in fighting the disease caused by the novel coronavirus. China is developing three vaccines that are now in Phase II...
Tags: Europe, Science, Saudi Arabia, China, Trends, United States, Xi Jinping, G20 Summit, Pfizer, Vaccines, Reuters, Riyadh, Xi, Matthew DeBord, Moderna, Coronavirus


Insider Transportation: the hottest startups ready to make flying cars real, the 737 MAX returns, and more

If you can't wait for the ROI from a flying car manufacturer like Lilium, consider investing in one of the startups building up the young industry's supply chain. Lilium Of all the wild truths that have emerged over the first 11 months of the year 2020, one of the few that sits closer to exhilarating than exasperating is that the flying car is just a few years away. That waiting time doesn't seem so bad when you consider that this concept is nearly as old as the airplane itself, but...
Tags: Transportation, US, Trends, Tesla, UPS, Ford, Pfizer, Vaccines, Flying Cars, Faa, Boeing, Max, Penske, Alex Davies, Jim Farley, Rick Grimes


Your Field Guide to the Four Potential COVID-19 Vaccines

It’s been a busy month for coronavirus vaccine news. In the past few weeks, we’ve seen announcements of interim phase 3 trial results, final phase 3 trial results, an FDA application, and phase 2 results. By my count, that’s five news events about three vaccines. It’s a bit confusing. Read more...
Tags: Fda, Lifehacks, Vaccines, Coronavirus


Pfizer Just Filed for Emergency Approval of Its Covid-19 Vaccine. What's Next?

On Friday morning, Pfizer and BioNTech announced that they would be seeking an emergency use authorization from the Food and Drug Administration today for their jointly developed covid-19 vaccine. If granted, that would make this vaccine likely the first to reach the public in the U.S., followed closely by Moderna’s…Read more...
Tags: Science, Cdc, Food And Drug Administration, Fda, Pfizer, Vaccines, Moderna, BioNtech, Coronavirus, Covid 19


Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. Pfizer and BioNTech, who revealed earlier this week that their vaccine was 95% effective based on Phase 3 clinical trial data, are submitting for the emergency authorization in the U.S., as well as in Australia, Canada, Europe, Japan and the U....
Tags: Health, TC, Europe, Japan, Medicine, Australia, Tech, Medical Research, Canada, United States, United Kingdom, Vaccination, Fda, Pfizer, Biotech, Vaccines


Moderna's coronavirus vaccine doesn't need to be as icy cold as Pfizer's, and that could make it easier to distribute

Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study. Dado Ruvic/Reuters Moderna and Pfizer have both announced promising trial results this week, suggesting their coronavirus vaccines perform very well at preventing COVID-19 infections.  But Moderna's shots can be kept in the fridge for a month, while Pfizer's can only last five days that way.  Pfizer has developed special vaccine briefcases that can keep its shots frozen properly for ...
Tags: Science, News, US, Trends, Public Health, Fda, Pfizer, Vaccines, Reuters, US Food and Drug Administration FDA, Baltimore Maryland, University of Maryland School of Medicine, Adalja, Amesh Adalja, Pandemic, Moderna


Let's All Get Cautiously Excited About This Vaccine News

On Wednesday, the pharmaceutical company Pfizer announced even more encouraging results from its now-completed covid-19 vaccine trial. The experimental vaccine appears to be 95% effective at preventing illness overall and seems nearly as effective in people over the age of 65, a key population. Despite the very…Read more...
Tags: Science, Pfizer, Vaccines, Pandemic, Coronavirus, Covid 19


Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a 90% effectiveness metric based on preliminary analysis of the Phase 3 trial data. This result also follows a preliminary data report from Moderna about their own Phase...
Tags: Health, TC, Medicine, Tech, Medical Research, Pfizer, Vaccine, Biotech, Vaccines, U S Food and Drug Administration FDA, EUA, Moderna, BioNtech, Coronavirus, COVID-19, COVID


U.S. Could See 2,000 Covid-19 Deaths Per Day by Christmas: Report

The U.S. could see 2,000 Americans dying per day by Christmas if strict new mitigation strategies aren’t adopted, according to warnings from doctors on the White House Coronavirus Task Force and a new report from CBS News. The alarming news comes as the U.S. reports 1,565 deaths from covid-19 on Tuesday alone, with…Read more...
Tags: Health, Science, Thanksgiving, Minnesota, Cbs News, Nurses, White House, Christmas, Joe Biden, Ptsd, Healthcare, Doctors, Wisconsin, Pfizer, Vaccines, Illinois


Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.

Mustafa Gerek participates in a coronavirus vaccine trial at Ankara City Hospital in Ankara, Turkey, October 13, 2020. Aytac Unal/Anadolu Agency via Getty Images The coronavirus vaccine candidates from Pfizer and Moderna both prevented COVID-19 in clinical trials. Research suggests the coronavirus is genetically stable, which means it mutates very slowly. So the leading vaccines should work well long-term against all strains of the virus. By contrast, viruses like the flu accumulate geneti...
Tags: Health, Science, News, China, Trends, Paris, Switzerland, Fda, Pfizer, Vaccines, Seattle, Mutations, Wuhan, Mount Sinai, Don, Bedford


It'll take weeks to vet a COVID-19 vaccine

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,If coronavirus vaccine results weren't quite enough breaking news for you this week, Amazon has officially unveiled its long-awaited Amazon Pharmacy service, selling prescription medications and offering discount services for Prime members. Much like Amazon's original fo...
Tags: Amazon, Trends, Walgreens, Bill Gates, Healthcare, Food And Drug Administration, Miami, Philadelphia, Fda, Pfizer, Vaccines, Morgan Stanley, Anthony Fauci, Nih, Business Insider, Trump


Moderna and Pfizer's coronavirus vaccines are more than 90% effective. Here's how that compares to shots for the flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. Pfizer announced last week that its coronavirus vaccine candidate was found to be more than 90% effective. The chart below shows how those vaccine candidates' efficacy c...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Moderna


Dr. Anthony Fauci and Bill Gates: Some coronavirus vaccines may work better in certain populations than others

Dr. Anthony Fauci said a coronavirus vaccine wouldn't be ready until January 2021. Reuters, Al Drago/AFP via Getty Images There won't be just one coronavirus vaccine "winner," but hopefully 4 or 5, Dr. Anthony Fauci told Rashida Jones on the new podcast she hosts with Bill Gates.  Gates and Fauci agreed that some vaccines may be more effective in certain populations than others. Each vaccine may also vary in how effectively it prevents transmission of the virus, which will be "confusin...
Tags: South Korea, Science, Microsoft, Australia, Trends, United States, Bill Gates, Fda, Pfizer, Vaccines, Anthony Fauci, Gates, Rashida Jones, Fauci, Moderna, Getty Images There


There's New Coronavirus Vaccine Data, and It's Okay to Actually Feel Hopeful

Today, Moderna announced that its coronavirus vaccine appears to be 94.5% effective. It’s the second vaccine candidate (after Pfizer’s, at 90%) to give us an early peek at their phase three results, and once again the news is good, but comes with caveats.Read more...
Tags: Pfizer, Lifehacks, Vaccines, Moderna, Coronavirus


A Second Covid-19 Vaccine Appears Highly Effective in Early Data

On Monday, Moderna became the second company in as many weeks to announce that its experimental vaccine against covid-19 appears to be highly effective, at least at first glance. In early data, the company claimed that the vaccine was found to be more than 90 percent effective, while being relatively well tolerated by…Read more...
Tags: Science, Vaccines, Pandemic, Moderna, Coronavirus, Covid 19


Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial

Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that its COVID-19 vaccine candidate has shown efficacy of 94.5% in its first interim data analysis, which covers 95 confirmed COVID cases among its study participants, of which 90 were given the placebo, and only 5 received Moderna’s mRNA-based vaccine. Further, of 11 severe cases of COVID-19, none were found am...
Tags: Health, TC, Messenger, Medicine, Tech, Medical Research, Vaccination, National Institutes of Health, Fda, Pfizer, Vaccine, Biotech, Vaccines, EUA, Moderna, BioNtech


Elon Musk Has Conflicting COVID Tests and Starts Twitter Debate

Elon Musk is 49 so his risks are very low with COVID. Elon is a multi-billionaire and will be able to get the best treatments. Elon said he had the symptoms of a typical cold with nothing unusual so... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Tags: Elon Musk, Science, Technology, Medicine, World, Virus, Innovation, Vaccines, Elon, COVID-19, COVID Elon